Hotline: +86-18022463983    020-85206863

Global Early Cancer Detection Market Research Report 2024

Published Date: 2024-03-29   |   Pages: 73   |   Tables: 140   |  Medical Care

Body fluid samples were collected for early cancer detection, and CTC, ctDNA and other markers were captured to evaluate the tumor situation. It is non-invasive, efficient, sensitive and highly acceptable for patients.

The global Early Cancer Detection market was valued at US$ million in 2023 and is anticipated to reach US$ million by 2030, witnessing a CAGR of % during the forecast period 2024-2030.

The early cancer detection market is a rapidly evolving sector within the healthcare industry. Early detection of cancer is crucial for improving treatment outcomes and reducing mortality rates. Detecting cancer at an earlier stage allows for more effective treatment options and increases the chances of successful recovery. Various screening technologies are used for early cancer detection, including imaging techniques like mammography for breast cancer, colonoscopy for colorectal cancer, Pap smear for cervical cancer, and PSA blood test for prostate cancer. These screening methods have been widely adopted and are proven to be effective in detecting cancer at an early stage.

This report aims to provide a comprehensive presentation of the global market for Early Cancer Detection, with both quantitative and qualitative analysis, to help readers develop business/growth strategies, assess the market competitive situation, analyze their position in the current marketplace, and make informed business decisions regarding Early Cancer Detection.

Report Scope

The Early Cancer Detection market size, estimations, and forecasts are provided in terms of revenue ($ millions), considering 2023 as the base year, with history and forecast data for the period from 2019 to 2030. This report segments the global Early Cancer Detection market comprehensively. Regional market sizes, concerning products by Type, by Application, and by players, are also provided.

For a more in-depth understanding of the market, the report provides profiles of the competitive landscape, key competitors, and their respective market ranks. The report also discusses technological trends and new product developments.

The report will help the Early Cancer Detection companies, new entrants, and industry chain related companies in this market with information on the revenues, sales volume, and average price for the overall market and the sub-segments across the different segments, by company, by Type, by Application, and by regions.

Market Segmentation

By Company

GRAIL(Illumina)

Exact Sciences

Guardant Health

BGI

New Horizon Health

Epigenomics AG

Genetron Health

Berry Genomics

Segment by Type

ctDNA

CTC

Exosomes

Circulating protein

Segment by Application

Hospital

Clinic

Others

By Region

North America

United States

Canada

Europe

Germany

France

UK

Italy

Russia

Nordic Countries

Rest of Europe

Asia-Pacific

China

Japan

South Korea

Southeast Asia

India

Australia

Rest of Asia

Latin America

Mexico

Brazil

Rest of Latin America

Middle East & Africa

Turkey

Saudi Arabia

UAE

Rest of MEA

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (by Type, by Application, etc), including the market size of each market segment, future development potential, and so on. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Introduces executive summary of global market size, regional market size, this section also introduces the market dynamics, latest developments of the market, the driving factors and restrictive factors of the market, the challenges and risks faced by companies in the industry, and the analysis of relevant policies in the industry.

Chapter 3: Detailed analysis of Early Cancer Detection companies’ competitive landscape, revenue market share, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by Type, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by Application, covering the market size and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6, 7, 8, 9, 10: North America, Europe, Asia Pacific, Latin America, Middle East and Africa segment by country. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world.

Chapter 11: Provides profiles of key players, introducing the basic situation of the main companies in the market in detail, including product sales, revenue, price, gross margin, product introduction, recent development, etc.

Chapter 12: The main points and conclusions of the report.

Research Methodology

The research methodology employed has been subjected by numerous procedures in order to guarantee the quality and accuracy of the data contained within the reports. The analysts are employed full-time and received more than six months training to satisfy the standard of our company. Our methodology can be divided into five stages:


Stage 1 SECONDARY RESEARCH

The research team first collaborates with magazines, trade associations and administrative departments in the research field. The information provided by our internal documentation service is helpful for our further research. Our team has a wealth of experience and knowledge, and can effectively extract accurate information from existing resources.

 

Stage 2 PRIMARY RESEARCH:INTERVIEWS WITH TRADE SOURCES

After the first stage, the research team conducts a large number of face-to-face or telephone interviews with representative companies working in the research field. Analysts are trying to have an opportunity to talk to leading companies and small companies in the field. Upstream suppliers, manufacturers, distributors, importers, installers, wholesalers and consumers were included in the interview. The data collected during the interview were then carefully examined and compared with the secondary study.

 

Stage 3 ANALYSIS OF THE GATHERED DATA

The analysis team examines and synthesizes the data collected in the first two stages. In order to validate the data, a second round of interviews can be conducted.

 

Stage 4 QUANTITATIVE DATA

The quantitative data such as market estimates, production and capacity of manufacturer, market forecasts and investment feasibility is provided by our company. The data is based on the estimates obtained during stage 3.

 

Stage 5 QUALITY CONTROL

Before publishing, each report undergoes a rigorous review and editing process, which is done by the experience management team to ensure the reliability of the published data. Every analyst on the research team receives support and continuous training as part of our internal quality process.

 

1 Report Overview

1.1 Study Scope

1.2 Market Analysis by Type

1.2.1 Global Early Cancer Detection Market Size Growth Rate by Type: 2019 VS 2023 VS 2030

1.2.2 ctDNA

1.2.3 CTC

1.2.4 Exosomes

1.2.5 Circulating protein

1.3 Market by Application

1.3.1 Global Early Cancer Detection Market Growth by Application: 2019 VS 2023 VS 2030

1.3.2 Hospital

1.3.3 Clinic

1.3.4 Others

1.4 Study Objectives

1.5 Years Considered

1.6 Years Considered

2 Global Growth Trends

2.1 Global Early Cancer Detection Market Perspective (2019-2030)

2.2 Early Cancer Detection Growth Trends by Region

2.2.1 Global Early Cancer Detection Market Size by Region: 2019 VS 2023 VS 2030

2.2.2 Early Cancer Detection Historic Market Size by Region (2019-2024)

2.2.3 Early Cancer Detection Forecasted Market Size by Region (2025-2030)

2.3 Early Cancer Detection Market Dynamics

2.3.1 Early Cancer Detection Industry Trends

2.3.2 Early Cancer Detection Market Drivers

2.3.3 Early Cancer Detection Market Challenges

2.3.4 Early Cancer Detection Market Restraints

3 Competition Landscape by Key Players

3.1 Global Top Early Cancer Detection Players by Revenue

3.1.1 Global Top Early Cancer Detection Players by Revenue (2019-2024)

3.1.2 Global Early Cancer Detection Revenue Market Share by Players (2019-2024)

3.2 Global Early Cancer Detection Market Share by Company Type (Tier 1, Tier 2, and Tier 3)

3.3 Players Covered: Ranking by Early Cancer Detection Revenue

3.4 Global Early Cancer Detection Market Concentration Ratio

3.4.1 Global Early Cancer Detection Market Concentration Ratio (CR5 and HHI)

3.4.2 Global Top 10 and Top 5 Companies by Early Cancer Detection Revenue in 2023

3.5 Early Cancer Detection Key Players Head office and Area Served

3.6 Key Players Early Cancer Detection Product Solution and Service

3.7 Date of Enter into Early Cancer Detection Market

3.8 Mergers & Acquisitions, Expansion Plans

4 Early Cancer Detection Breakdown Data by Type

4.1 Global Early Cancer Detection Historic Market Size by Type (2019-2024)

4.2 Global Early Cancer Detection Forecasted Market Size by Type (2025-2030)

5 Early Cancer Detection Breakdown Data by Application

5.1 Global Early Cancer Detection Historic Market Size by Application (2019-2024)

5.2 Global Early Cancer Detection Forecasted Market Size by Application (2025-2030)

6 North America

6.1 North America Early Cancer Detection Market Size (2019-2030)

6.2 North America Early Cancer Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

6.3 North America Early Cancer Detection Market Size by Country (2019-2024)

6.4 North America Early Cancer Detection Market Size by Country (2025-2030)

6.5 United States

6.6 Canada

7 Europe

7.1 Europe Early Cancer Detection Market Size (2019-2030)

7.2 Europe Early Cancer Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

7.3 Europe Early Cancer Detection Market Size by Country (2019-2024)

7.4 Europe Early Cancer Detection Market Size by Country (2025-2030)

7.5 Germany

7.6 France

7.7 U.K.

7.8 Italy

7.9 Russia

7.10 Nordic Countries

8 Asia-Pacific

8.1 Asia-Pacific Early Cancer Detection Market Size (2019-2030)

8.2 Asia-Pacific Early Cancer Detection Market Growth Rate by Region: 2019 VS 2023 VS 2030

8.3 Asia-Pacific Early Cancer Detection Market Size by Region (2019-2024)

8.4 Asia-Pacific Early Cancer Detection Market Size by Region (2025-2030)

8.5 China

8.6 Japan

8.7 South Korea

8.8 Southeast Asia

8.9 India

8.10 Australia

9 Latin America

9.1 Latin America Early Cancer Detection Market Size (2019-2030)

9.2 Latin America Early Cancer Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

9.3 Latin America Early Cancer Detection Market Size by Country (2019-2024)

9.4 Latin America Early Cancer Detection Market Size by Country (2025-2030)

9.5 Mexico

9.6 Brazil

10 Middle East & Africa

10.1 Middle East & Africa Early Cancer Detection Market Size (2019-2030)

10.2 Middle East & Africa Early Cancer Detection Market Growth Rate by Country: 2019 VS 2023 VS 2030

10.3 Middle East & Africa Early Cancer Detection Market Size by Country (2019-2024)

10.4 Middle East & Africa Early Cancer Detection Market Size by Country (2025-2030)

10.5 Turkey

10.6 Saudi Arabia

10.7 UAE

11 Key Players Profiles

11.1 GRAIL(Illumina)

11.1.1 GRAIL(Illumina) Company Detail

11.1.2 GRAIL(Illumina) Business Overview

11.1.3 GRAIL(Illumina) Early Cancer Detection Introduction

11.1.4 GRAIL(Illumina) Revenue in Early Cancer Detection Business (2019-2024)

11.1.5 GRAIL(Illumina) Recent Development

11.2 Exact Sciences

11.2.1 Exact Sciences Company Detail

11.2.2 Exact Sciences Business Overview

11.2.3 Exact Sciences Early Cancer Detection Introduction

11.2.4 Exact Sciences Revenue in Early Cancer Detection Business (2019-2024)

11.2.5 Exact Sciences Recent Development

11.3 Guardant Health

11.3.1 Guardant Health Company Detail

11.3.2 Guardant Health Business Overview

11.3.3 Guardant Health Early Cancer Detection Introduction

11.3.4 Guardant Health Revenue in Early Cancer Detection Business (2019-2024)

11.3.5 Guardant Health Recent Development

11.4 BGI

11.4.1 BGI Company Detail

11.4.2 BGI Business Overview

11.4.3 BGI Early Cancer Detection Introduction

11.4.4 BGI Revenue in Early Cancer Detection Business (2019-2024)

11.4.5 BGI Recent Development

11.5 New Horizon Health

11.5.1 New Horizon Health Company Detail

11.5.2 New Horizon Health Business Overview

11.5.3 New Horizon Health Early Cancer Detection Introduction

11.5.4 New Horizon Health Revenue in Early Cancer Detection Business (2019-2024)

11.5.5 New Horizon Health Recent Development

11.6 Epigenomics AG

11.6.1 Epigenomics AG Company Detail

11.6.2 Epigenomics AG Business Overview

11.6.3 Epigenomics AG Early Cancer Detection Introduction

11.6.4 Epigenomics AG Revenue in Early Cancer Detection Business (2019-2024)

11.6.5 Epigenomics AG Recent Development

11.7 Genetron Health

11.7.1 Genetron Health Company Detail

11.7.2 Genetron Health Business Overview

11.7.3 Genetron Health Early Cancer Detection Introduction

11.7.4 Genetron Health Revenue in Early Cancer Detection Business (2019-2024)

11.7.5 Genetron Health Recent Development

11.8 Berry Genomics

11.8.1 Berry Genomics Company Detail

11.8.2 Berry Genomics Business Overview

11.8.3 Berry Genomics Early Cancer Detection Introduction

11.8.4 Berry Genomics Revenue in Early Cancer Detection Business (2019-2024)

11.8.5 Berry Genomics Recent Development

12 Analyst's Viewpoints/Conclusions

13 Appendix

13.1 Research Methodology

13.1.1 Methodology/Research Approach

13.1.2 Data Source

13.2 Disclaimer

13.3 Author Details

List of Tables

Table 1. Global Early Cancer Detection Market Size Growth Rate by Type (US$ Million): 2019 VS 2023 VS 2030

Table 2. Key Players of ctDNA

Table 3. Key Players of CTC

Table 4. Key Players of Exosomes

Table 5. Key Players of Circulating protein

Table 6. Global Early Cancer Detection Market Size Growth by Application (US$ Million): 2019 VS 2023 VS 2030

Table 7. Global Early Cancer Detection Market Size by Region (US$ Million): 2019 VS 2023 VS 2030

Table 8. Global Early Cancer Detection Market Size by Region (2019-2024) & (US$ Million)

Table 9. Global Early Cancer Detection Market Share by Region (2019-2024)

Table 10. Global Early Cancer Detection Forecasted Market Size by Region (2025-2030) & (US$ Million)

Table 11. Global Early Cancer Detection Market Share by Region (2025-2030)

Table 12. Early Cancer Detection Market Trends

Table 13. Early Cancer Detection Market Drivers

Table 14. Early Cancer Detection Market Challenges

Table 15. Early Cancer Detection Market Restraints

Table 16. Global Early Cancer Detection Revenue by Players (2019-2024) & (US$ Million)

Table 17. Global Early Cancer Detection Market Share by Players (2019-2024)

Table 18. Global Top Early Cancer Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Early Cancer Detection as of 2023)

Table 19. Ranking of Global Top Early Cancer Detection Companies by Revenue (US$ Million) in 2023

Table 20. Global 5 Largest Players Market Share by Early Cancer Detection Revenue (CR5 and HHI) & (2019-2024)

Table 21. Key Players Headquarters and Area Served

Table 22. Key Players Early Cancer Detection Product Solution and Service

Table 23. Date of Enter into Early Cancer Detection Market

Table 24. Mergers & Acquisitions, Expansion Plans

Table 25. Global Early Cancer Detection Market Size by Type (2019-2024) & (US$ Million)

Table 26. Global Early Cancer Detection Revenue Market Share by Type (2019-2024)

Table 27. Global Early Cancer Detection Forecasted Market Size by Type (2025-2030) & (US$ Million)

Table 28. Global Early Cancer Detection Revenue Market Share by Type (2025-2030)

Table 29. Global Early Cancer Detection Market Size by Application (2019-2024) & (US$ Million)

Table 30. Global Early Cancer Detection Revenue Market Share by Application (2019-2024)

Table 31. Global Early Cancer Detection Forecasted Market Size by Application (2025-2030) & (US$ Million)

Table 32. Global Early Cancer Detection Revenue Market Share by Application (2025-2030)

Table 33. North America Early Cancer Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 34. North America Early Cancer Detection Market Size by Country (2019-2024) & (US$ Million)

Table 35. North America Early Cancer Detection Market Size by Country (2025-2030) & (US$ Million)

Table 36. Europe Early Cancer Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 37. Europe Early Cancer Detection Market Size by Country (2019-2024) & (US$ Million)

Table 38. Europe Early Cancer Detection Market Size by Country (2025-2030) & (US$ Million)

Table 39. Asia-Pacific Early Cancer Detection Market Size Growth Rate by Region (US$ Million): 2019 VS 2023 VS 2030

Table 40. Asia-Pacific Early Cancer Detection Market Size by Region (2019-2024) & (US$ Million)

Table 41. Asia-Pacific Early Cancer Detection Market Size by Region (2025-2030) & (US$ Million)

Table 42. Latin America Early Cancer Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 43. Latin America Early Cancer Detection Market Size by Country (2019-2024) & (US$ Million)

Table 44. Latin America Early Cancer Detection Market Size by Country (2025-2030) & (US$ Million)

Table 45. Middle East & Africa Early Cancer Detection Market Size Growth Rate by Country (US$ Million): 2019 VS 2023 VS 2030

Table 46. Middle East & Africa Early Cancer Detection Market Size by Country (2019-2024) & (US$ Million)

Table 47. Middle East & Africa Early Cancer Detection Market Size by Country (2025-2030) & (US$ Million)

Table 48. GRAIL(Illumina) Company Detail

Table 49. GRAIL(Illumina) Business Overview

Table 50. GRAIL(Illumina) Early Cancer Detection Product

Table 51. GRAIL(Illumina) Revenue in Early Cancer Detection Business (2019-2024) & (US$ Million)

Table 52. GRAIL(Illumina) Recent Development

Table 53. Exact Sciences Company Detail

Table 54. Exact Sciences Business Overview

Table 55. Exact Sciences Early Cancer Detection Product

Table 56. Exact Sciences Revenue in Early Cancer Detection Business (2019-2024) & (US$ Million)

Table 57. Exact Sciences Recent Development

Table 58. Guardant Health Company Detail

Table 59. Guardant Health Business Overview

Table 60. Guardant Health Early Cancer Detection Product

Table 61. Guardant Health Revenue in Early Cancer Detection Business (2019-2024) & (US$ Million)

Table 62. Guardant Health Recent Development

Table 63. BGI Company Detail

Table 64. BGI Business Overview

Table 65. BGI Early Cancer Detection Product

Table 66. BGI Revenue in Early Cancer Detection Business (2019-2024) & (US$ Million)

Table 67. BGI Recent Development

Table 68. New Horizon Health Company Detail

Table 69. New Horizon Health Business Overview

Table 70. New Horizon Health Early Cancer Detection Product

Table 71. New Horizon Health Revenue in Early Cancer Detection Business (2019-2024) & (US$ Million)

Table 72. New Horizon Health Recent Development

Table 73. Epigenomics AG Company Detail

Table 74. Epigenomics AG Business Overview

Table 75. Epigenomics AG Early Cancer Detection Product

Table 76. Epigenomics AG Revenue in Early Cancer Detection Business (2019-2024) & (US$ Million)

Table 77. Epigenomics AG Recent Development

Table 78. Genetron Health Company Detail

Table 79. Genetron Health Business Overview

Table 80. Genetron Health Early Cancer Detection Product

Table 81. Genetron Health Revenue in Early Cancer Detection Business (2019-2024) & (US$ Million)

Table 82. Genetron Health Recent Development

Table 83. Berry Genomics Company Detail

Table 84. Berry Genomics Business Overview

Table 85. Berry Genomics Early Cancer Detection Product

Table 86. Berry Genomics Revenue in Early Cancer Detection Business (2019-2024) & (US$ Million)

Table 87. Berry Genomics Recent Development

Table 88. Research Programs/Design for This Report

Table 89. Key Data Information from Secondary Sources

Table 90. Key Data Information from Primary Sources

List of Figures

Figure 1. Global Early Cancer Detection Market Size Comparison by Type (2024-2030) & (US$ Million)

Figure 2. Global Early Cancer Detection Market Share by Type: 2023 VS 2030

Figure 3. ctDNA Features

Figure 4. CTC Features

Figure 5. Exosomes Features

Figure 6. Circulating protein Features

Figure 7. Global Early Cancer Detection Market Size Comparison by Application (2024-2030) & (US$ Million)

Figure 8. Global Early Cancer Detection Market Share by Application: 2023 VS 2030

Figure 9. Hospital Case Studies

Figure 10. Clinic Case Studies

Figure 11. Others Case Studies

Figure 12. Early Cancer Detection Report Years Considered

Figure 13. Global Early Cancer Detection Market Size (US$ Million), Year-over-Year: 2019-2030

Figure 14. Global Early Cancer Detection Market Size, (US$ Million), 2019 VS 2023 VS 2030

Figure 15. Global Early Cancer Detection Market Share by Region: 2023 VS 2030

Figure 16. Global Early Cancer Detection Market Share by Players in 2023

Figure 17. Global Top Early Cancer Detection Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Early Cancer Detection as of 2023)

Figure 18. The Top 10 and 5 Players Market Share by Early Cancer Detection Revenue in 2023

Figure 19. North America Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 20. North America Early Cancer Detection Market Share by Country (2019-2030)

Figure 21. United States Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 22. Canada Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 23. Europe Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 24. Europe Early Cancer Detection Market Share by Country (2019-2030)

Figure 25. Germany Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 26. France Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 27. U.K. Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 28. Italy Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 29. Russia Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 30. Nordic Countries Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 31. Asia-Pacific Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 32. Asia-Pacific Early Cancer Detection Market Share by Region (2019-2030)

Figure 33. China Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 34. Japan Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 35. South Korea Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 36. Southeast Asia Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 37. India Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 38. Australia Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 39. Latin America Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 40. Latin America Early Cancer Detection Market Share by Country (2019-2030)

Figure 41. Mexico Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 42. Brazil Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 43. Middle East & Africa Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 44. Middle East & Africa Early Cancer Detection Market Share by Country (2019-2030)

Figure 45. Turkey Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 46. Saudi Arabia Early Cancer Detection Market Size YoY Growth (2019-2030) & (US$ Million)

Figure 47. GRAIL(Illumina) Revenue Growth Rate in Early Cancer Detection Business (2019-2024)

Figure 48. Exact Sciences Revenue Growth Rate in Early Cancer Detection Business (2019-2024)

Figure 49. Guardant Health Revenue Growth Rate in Early Cancer Detection Business (2019-2024)

Figure 50. BGI Revenue Growth Rate in Early Cancer Detection Business (2019-2024)

Figure 51. New Horizon Health Revenue Growth Rate in Early Cancer Detection Business (2019-2024)

Figure 52. Epigenomics AG Revenue Growth Rate in Early Cancer Detection Business (2019-2024)

Figure 53. Genetron Health Revenue Growth Rate in Early Cancer Detection Business (2019-2024)

Figure 54. Berry Genomics Revenue Growth Rate in Early Cancer Detection Business (2019-2024)

Figure 55. Bottom-up and Top-down Approaches for This Report

Figure 56. Data Triangulation

Figure 57. Key Executives Interviewed

Our Clients